Back
Reshape Lifesciences Stock Price Chart
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.
Sell
19
RSLS
Reshape Lifesciences
Last Price:
$4.29
Seasonality Move:
-31.26%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing selling pressure, which indicates risk of future bearish movement.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.93 | Sell |
| 20-day SMA: | 5.82 | Sell |
| 50-day SMA: | 8.96 | Sell |
| 200-day SMA: | 95.44 | Sell |
| 8-day EMA: | 5.21 | Sell |
| 20-day EMA: | 6.13 | Sell |
| 50-day EMA: | 13.43 | Sell |
| 200-day EMA: | 246.58 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.5 | Sell |
| Relative Strength Index (14 RSI): | 40.88 | Sell |
| Chaikin Money Flow: | -1094051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.63 - 8.61) | Sell |
| Bollinger Bands (100): | (-3.46 - 71.36) | Sell |
Reshape Lifesciences Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 4.83 while RSLS 8-day simple moving average is 4.93, which is a Sell signal.
-
The stock price of RSLS is 4.83 while Reshape Lifesciences 20-day SMA is 5.82, which makes it a Sell.
-
Reshape Lifesciences 50-day simple moving average is 8.96 while RSLS share price is 4.83, making it a Sell technically.
-
RSLS stock price is 4.83 and Reshape Lifesciences 200-day simple moving average is 95.44, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
19
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $4.83. The Score for RSLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
3.6M
Price in USD:
4.83
Share Volume:
1.4M
Reshape Lifesciences 52-Week Range
52-Week High:
415.00
52-Week Low:
4.03
Sell
19
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 4.83 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 4.83 while RSLS 8-day exponential moving average is 5.21, which is a Sell signal.
-
The stock price of RSLS is 4.83 while Reshape Lifesciences 20-day EMA is 6.13, which makes it a Sell.
-
Reshape Lifesciences 50-day exponential moving average is 13.43 while RSLS share price is 4.83, making it a Sell technically.
-
RSLS stock price is 4.83 and Reshape Lifesciences 200-day simple moving average is 246.58, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -1.5, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 40.88, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (4.63 - 8.61), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (-3.46 - 71.36), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.